As of Jun 29
| -0.025 / -0.16%|
The 8 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 17.84, with a high estimate of 19.18 and a low estimate of 14.40. The median estimate represents a +12.75% increase from the last price of 15.82.
The current consensus among 8 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.